Targeted Oncology™ Community Case Forum™
Friday September 19, 2025 | 1:00 - 3:30 PM CT
The Westin Galleria Houston | Houston, TX
Presented in partnership and conjunction with the TxSCO 2025 Annual Conference
CONNECT WITH THE COMMUNITY
The Community Case Forum is a special opportunity to gather IN-PERSON only.
No virtual options are available.
After arriving at registration check-in, you'll spend some time networking with peers while enjoying small plate refreshments and cocktails. Case-based discussions will follow the networking reception and the evening will adjourn by 3:30 PM.
Eligibility
Participants must be medical oncologists or hematologists currently treating patients in a community practice setting. With prior approval from our registration team, a small number of fellows and advanced practice providers may be eligible to attend.
Discussion Topics
You choose the topic that is best aligned for the patients you're seeing in your practice now. Our moderators will present case-based clinical profiles to generate discussion among participants around recent clinical data and potential treatment strategies.
Discussion Topics Include:
Exploring T-Cell Redirection Therapies in R/R LBCL
During this conversation we will explore two clinical cases, focusing on T-cell redirection therapy strategies including CAR T-cell therapies and bispecific antibodies for patients with R/R LBCL. We will examine one case in the second-line (2L) setting and one case in the third-line (3L) setting, highlighting the evolving landscape of these innovative approaches.
Moderated by: Sairah Ahmed, MD (The University of Texas MD Anderson Cancer Center)
Prostate Cancer: Castration-Resistant
During this conversation we will cover two clinical cases of CRPC: one non-metastatic and one metastatic.
Moderated by: Eleni Efstathiou, MD, PhD (Houston Methodist)
MARKET RESEARCH PARTICIPATION
Seating is limited, and registration will close when capacity is reached.
Reserve your seat today for the Targeted Oncology Community Case Forum.
Presented in Partnership With:
Targeted Healthcare Communications® — an MJH Life Sciences® Brand
Copyright 2025 © Intellisphere, LLC. All Rights Reserved.